Cargando…
EPAC2: A new and promising protein for glioma pathogenesis and therapy
Gliomas are prime brain cancers which are initiated by malignant modification of neural stem cells, progenitor cells and differentiated glial cells such as astrocyte, oligodendrocyte as well as ependymal cells. Exchange proteins directly activated by cAMP (EPACs) are crucial cyclic adenosine 3’,5’-m...
Autor principal: | Richard, Seidu A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204831/ https://www.ncbi.nlm.nih.gov/pubmed/32395202 http://dx.doi.org/10.4081/oncol.2020.446 |
Ejemplares similares
-
Overexpression of EPAC2 reduces the invasion of glioma cells via MMP-2
por: Jiang, Ming, et al.
Publicado: (2019) -
The Pivotal Immunoregulatory Functions of Microglia and Macrophages in Glioma Pathogenesis and Therapy
por: Richard, Seidu A.
Publicado: (2022) -
Epac: new emerging cAMP-binding protein
por: Lee, Kyungmin
Publicado: (2021) -
Structure-Guided Design of Selective Epac1 and Epac2 Agonists
por: Schwede, Frank, et al.
Publicado: (2015) -
Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
por: Pan, Yunfeng, et al.
Publicado: (2022)